Are Andrew Yule & Company Ltd latest results good or bad?

Feb 12 2026 07:56 PM IST
share
Share Via
Andrew Yule & Company Ltd's latest results show a 9.76% revenue growth to ₹75.00 crores, but the company reported a consolidated net loss of ₹8.80 crores and significant operational challenges, indicating a negative outlook despite top-line growth.
The latest financial results for Andrew Yule & Company Ltd reveal a complex operational landscape characterized by persistent challenges despite some revenue growth. In the third quarter of FY26, the company reported consolidated net sales of ₹75.00 crores, reflecting a year-on-year growth of 9.76% compared to ₹68.33 crores in the same quarter of the previous fiscal year. However, this revenue growth has not translated into profitability, as the company recorded a consolidated net loss of ₹8.80 crores, which represents a significant deterioration from the previous quarter's loss.
The operational metrics indicate a concerning trend, with the operating profit before depreciation, interest, and tax (excluding other income) showing a loss of ₹13.78 crores, leading to an operating margin of -18.54%. This marks a notable decline from the -6.45% margin reported in the previous quarter. The high employee cost ratio, consuming 66.65% of total revenues, underscores the structural challenges the company faces in managing its cost base effectively. Additionally, the return on equity remains low at 1.34%, indicating weak capital efficiency, while the return on capital employed is reported at -26.94%. These figures highlight the ongoing difficulties in generating adequate returns from the company's operations. The company also experienced a significant decline in other income, which fell sharply from ₹59.71 crores in Q1 FY26 to ₹9.64 crores in Q3 FY26, further exacerbating the financial strain. The increase in interest expenses to ₹5.33 crores in Q3 FY26 adds to the pressure on the bottom line. Overall, Andrew Yule & Company Ltd's results reflect a company grappling with persistent operational losses and structural challenges, despite some top-line growth. The evaluation of the company has seen an adjustment, indicating a shift in how its financial health is perceived. The outlook remains uncertain, with limited visibility on a turnaround without significant restructuring efforts.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News